We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fluorescence-Based Method Detects Misfolded Proteins in Cells

By LabMedica International staff writers
Posted on 25 Feb 2019
A new fluorescence-based method is expected to boost studies on toxic insoluble proteins by detecting aggregation of two proteins in live cells simultaneously.

Protein aggregation involves the assembly of partially misfolded proteins into oligomeric and higher‐order structures that have been associated with several neurodegenerative diseases. More...
However, numerous questions regarding protein aggregation remain unanswered due to the lack of available tools to visualize these species in living cells.

In this regard, investigators at Pennsylvania State University (University Park, USA) recently (published in the June 8, 2018, online edition of the Journal of the American Chemical Society) developed a fluorogenic method named Aggregation Tag (AggTag), and presented the AggTag probe P1 based on a Halo‐tag ligand to report on the aggregation of a protein of interest in live cells. Halo-tag is a self-labeling protein tag. It is a 297-residue peptide derived from a bacterial enzyme, designed to covalently bind to a synthetic ligand of choice and fuse to a protein of interest. The Halo-tag is composed of two covalently bound segments including a haloalkane dehalogenase and a synthetic ligand of choice. These synthetic ligands consist of a reactive chloroalkane linker bound to a functional group such as biotin or a fluorescent dye, which can be used in the visualization of either living or chemically fixed cells.

Since the Halo‐tag based AggTag method only detected the aggregation of one specific protein of interest at a time, the investigators expanded the AggTag method by using SNAP‐tag technology to enable fluorogenic and biorthogonal detection of the aggregation of two different proteins of interest simultaneously in live cells. A new AggTag probe P2 based on a SNAP‐tag ligand bearing a green fluorescent label was synthesized for this purpose. SNAP-tag is a self-labeling protein tag commercially available in various expression vectors. It is a 182 residues polypeptide that can be fused to any protein of interest and further specifically and covalently tagged with a suitable ligand, such as a fluorescent dye.

The investigators reported in the January 4, 2019, online edition of the journal ChemBioChem that by using confocal imaging and chemical crosslinking experiments, they were able to confirm that P2 could also report on both soluble oligomers and insoluble aggregates of a protein of interest fused with SNAP‐tag in live cells. In addition, they showed that the orthogonal fluorescence of P1 and P2 allowed for simultaneous visualization of two different pathogenic protein aggregates in the same cells.

"In order to function properly, proteins fold into very precise structures, but environmental stress or pathogenic mutations can cause proteins to misfold and aggregate," said senior author Dr. Xin Zhang, assistant professor of chemistry, biochemistry, and molecular biology at Pennsylvania State University. "Protein aggregation is a multi-step process, and it is believed that the intermediate form, which previous imaging techniques could not detect, is responsible for a number of diseases, including Alzheimer's, Parkinson's, Type II diabetes, and cystic fibrosis. We developed the Aggregation Tag method--AggTag--to see these previously undetectable intermediates--soluble oligomers--as well the final aggregates in live cells."

"We plan to continue developing this method so that we can signal the transition of oligomers into insoluble aggregates using a color change," said Dr. Zhang. "This method provides a new toolbox to study protein aggregation, which is currently a highly studied topic among scientists. Hopefully this will allow us to better understand the entire process of protein aggregation and the role of each of these forms in the progression of neurodegenerative and other diseases."

Related Links:
Pennsylvania State University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.